nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—AR—scrotum—colon cancer	0.0581	0.17	CbGeAlD
Danazol—CCL2—endothelium—colon cancer	0.0245	0.0715	CbGeAlD
Danazol—CCL2—blood vessel—colon cancer	0.0226	0.0659	CbGeAlD
Danazol—CCL2—gall bladder—colon cancer	0.0212	0.0621	CbGeAlD
Danazol—Arterial thrombosis—Irinotecan—colon cancer	0.0136	0.0442	CcSEcCtD
Danazol—CCL2—embryo—colon cancer	0.0135	0.0393	CbGeAlD
Danazol—Guillain-Barre syndrome—Methotrexate—colon cancer	0.0126	0.0408	CcSEcCtD
Danazol—PGR—blood vessel—colon cancer	0.0119	0.0347	CbGeAlD
Danazol—CCL2—epithelium—colon cancer	0.011	0.0321	CbGeAlD
Danazol—CCL2—smooth muscle tissue—colon cancer	0.0106	0.0309	CbGeAlD
Danazol—CCL2—renal system—colon cancer	0.0102	0.0298	CbGeAlD
Danazol—ESR1—blood vessel—colon cancer	0.00928	0.0271	CbGeAlD
Danazol—CCL2—lymphoid tissue—colon cancer	0.00846	0.0247	CbGeAlD
Danazol—CCL2—digestive system—colon cancer	0.00836	0.0244	CbGeAlD
Danazol—CCL2—bone marrow—colon cancer	0.0077	0.0225	CbGeAlD
Danazol—CCL2—vagina—colon cancer	0.00738	0.0216	CbGeAlD
Danazol—Pigmentation disorder—Capecitabine—colon cancer	0.00736	0.0238	CcSEcCtD
Danazol—Arterial thrombosis—Methotrexate—colon cancer	0.00679	0.022	CcSEcCtD
Danazol—CCL2—liver—colon cancer	0.00623	0.0182	CbGeAlD
Danazol—Nodule—Methotrexate—colon cancer	0.00622	0.0202	CcSEcCtD
Danazol—PGR—epithelium—colon cancer	0.00577	0.0169	CbGeAlD
Danazol—Hoarseness—Capecitabine—colon cancer	0.00558	0.0181	CcSEcCtD
Danazol—PGR—smooth muscle tissue—colon cancer	0.00556	0.0163	CbGeAlD
Danazol—ESR1—embryo—colon cancer	0.00553	0.0162	CbGeAlD
Danazol—Thrombosis—Irinotecan—colon cancer	0.00518	0.0168	CcSEcCtD
Danazol—Joint swelling—Capecitabine—colon cancer	0.00501	0.0162	CcSEcCtD
Danazol—CCL2—lymph node—colon cancer	0.00477	0.0139	CbGeAlD
Danazol—AR—epithelium—colon cancer	0.0046	0.0134	CbGeAlD
Danazol—ESR1—epithelium—colon cancer	0.00452	0.0132	CbGeAlD
Danazol—SHBG—bone marrow—colon cancer	0.00449	0.0131	CbGeAlD
Danazol—PGR—lymphoid tissue—colon cancer	0.00445	0.013	CbGeAlD
Danazol—AR—smooth muscle tissue—colon cancer	0.00443	0.013	CbGeAlD
Danazol—ESR1—smooth muscle tissue—colon cancer	0.00435	0.0127	CbGeAlD
Danazol—SHBG—vagina—colon cancer	0.00431	0.0126	CbGeAlD
Danazol—AR—renal system—colon cancer	0.00427	0.0125	CbGeAlD
Danazol—Hirsutism—Capecitabine—colon cancer	0.00423	0.0137	CcSEcCtD
Danazol—ESR1—renal system—colon cancer	0.00419	0.0122	CbGeAlD
Danazol—PGR—vagina—colon cancer	0.00388	0.0113	CbGeAlD
Danazol—Interstitial pneumonia—Methotrexate—colon cancer	0.00378	0.0123	CcSEcCtD
Danazol—Leukocytosis—Fluorouracil—colon cancer	0.00374	0.0121	CcSEcCtD
Danazol—SHBG—liver—colon cancer	0.00363	0.0106	CbGeAlD
Danazol—AR—lymphoid tissue—colon cancer	0.00354	0.0104	CbGeAlD
Danazol—AR—digestive system—colon cancer	0.0035	0.0102	CbGeAlD
Danazol—ESR1—lymphoid tissue—colon cancer	0.00348	0.0102	CbGeAlD
Danazol—Thrombosis—Capecitabine—colon cancer	0.00347	0.0112	CcSEcCtD
Danazol—ESR1—digestive system—colon cancer	0.00344	0.01	CbGeAlD
Danazol—Throat sore—Capecitabine—colon cancer	0.00341	0.011	CcSEcCtD
Danazol—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00338	0.0109	CcSEcCtD
Danazol—AR—vagina—colon cancer	0.00309	0.00903	CbGeAlD
Danazol—ESR1—vagina—colon cancer	0.00303	0.00886	CbGeAlD
Danazol—Dysphonia—Capecitabine—colon cancer	0.00298	0.00968	CcSEcCtD
Danazol—CYP19A1—liver—colon cancer	0.00294	0.0086	CbGeAlD
Danazol—Photosensitivity—Fluorouracil—colon cancer	0.0029	0.00942	CcSEcCtD
Danazol—Visual disturbance—Irinotecan—colon cancer	0.00281	0.00911	CcSEcCtD
Danazol—Oropharyngeal pain—Capecitabine—colon cancer	0.0027	0.00875	CcSEcCtD
Danazol—AR—liver—colon cancer	0.00261	0.00762	CbGeAlD
Danazol—Interstitial lung disease—Methotrexate—colon cancer	0.00258	0.00837	CcSEcCtD
Danazol—Cataract—Capecitabine—colon cancer	0.00258	0.00836	CcSEcCtD
Danazol—ESR1—liver—colon cancer	0.00256	0.00748	CbGeAlD
Danazol—PGR—lymph node—colon cancer	0.00251	0.00733	CbGeAlD
Danazol—Irritability—Fluorouracil—colon cancer	0.00243	0.00789	CcSEcCtD
Danazol—Cramp muscle—Irinotecan—colon cancer	0.0024	0.00778	CcSEcCtD
Danazol—CYP3A4—renal system—colon cancer	0.00234	0.00683	CbGeAlD
Danazol—Fluid retention—Capecitabine—colon cancer	0.00233	0.00756	CcSEcCtD
Danazol—CYP19A1—lymph node—colon cancer	0.00226	0.0066	CbGeAlD
Danazol—Pancreatitis—Irinotecan—colon cancer	0.00226	0.00732	CcSEcCtD
Danazol—Eosinophilia—Fluorouracil—colon cancer	0.00218	0.00708	CcSEcCtD
Danazol—Photosensitivity reaction—Vincristine—colon cancer	0.00216	0.00699	CcSEcCtD
Danazol—Acute coronary syndrome—Vincristine—colon cancer	0.00208	0.00674	CcSEcCtD
Danazol—Myocardial infarction—Vincristine—colon cancer	0.00207	0.0067	CcSEcCtD
Danazol—Sleep disorder—Capecitabine—colon cancer	0.00206	0.00668	CcSEcCtD
Danazol—Hepatic function abnormal—Capecitabine—colon cancer	0.00204	0.00661	CcSEcCtD
Danazol—Photosensitivity—Capecitabine—colon cancer	0.00203	0.00658	CcSEcCtD
Danazol—Acute coronary syndrome—Irinotecan—colon cancer	0.00202	0.00656	CcSEcCtD
Danazol—Sweating—Vincristine—colon cancer	0.00202	0.00655	CcSEcCtD
Danazol—Photosensitivity reaction—Fluorouracil—colon cancer	0.00201	0.00652	CcSEcCtD
Danazol—Myocardial infarction—Irinotecan—colon cancer	0.00201	0.00652	CcSEcCtD
Danazol—Gastroenteritis—Capecitabine—colon cancer	0.00201	0.00652	CcSEcCtD
Danazol—Jaundice—Irinotecan—colon cancer	0.002	0.00649	CcSEcCtD
Danazol—AR—lymph node—colon cancer	0.002	0.00584	CbGeAlD
Danazol—Sweating—Irinotecan—colon cancer	0.00197	0.00638	CcSEcCtD
Danazol—ESR1—lymph node—colon cancer	0.00196	0.00573	CbGeAlD
Danazol—Acute coronary syndrome—Fluorouracil—colon cancer	0.00194	0.00628	CcSEcCtD
Danazol—Myocardial infarction—Fluorouracil—colon cancer	0.00193	0.00625	CcSEcCtD
Danazol—CYP3A4—digestive system—colon cancer	0.00192	0.0056	CbGeAlD
Danazol—Haemoglobin—Irinotecan—colon cancer	0.00185	0.006	CcSEcCtD
Danazol—Haemorrhage—Irinotecan—colon cancer	0.00184	0.00597	CcSEcCtD
Danazol—Visual impairment—Irinotecan—colon cancer	0.00178	0.00576	CcSEcCtD
Danazol—Haemoglobin—Fluorouracil—colon cancer	0.00177	0.00575	CcSEcCtD
Danazol—Haemorrhage—Fluorouracil—colon cancer	0.00176	0.00572	CcSEcCtD
Danazol—Migraine—Capecitabine—colon cancer	0.00175	0.00569	CcSEcCtD
Danazol—Flushing—Irinotecan—colon cancer	0.00171	0.00554	CcSEcCtD
Danazol—Irritability—Capecitabine—colon cancer	0.0017	0.00552	CcSEcCtD
Danazol—Mood swings—Capecitabine—colon cancer	0.00169	0.00547	CcSEcCtD
Danazol—Alopecia—Vincristine—colon cancer	0.00167	0.00542	CcSEcCtD
Danazol—Chills—Irinotecan—colon cancer	0.00165	0.00536	CcSEcCtD
Danazol—Alopecia—Irinotecan—colon cancer	0.00163	0.00528	CcSEcCtD
Danazol—Abdominal pain upper—Capecitabine—colon cancer	0.00163	0.00528	CcSEcCtD
Danazol—Back pain—Vincristine—colon cancer	0.00159	0.00516	CcSEcCtD
Danazol—Alopecia—Fluorouracil—colon cancer	0.00156	0.00506	CcSEcCtD
Danazol—Back pain—Irinotecan—colon cancer	0.00155	0.00503	CcSEcCtD
Danazol—Muscle spasms—Irinotecan—colon cancer	0.00154	0.005	CcSEcCtD
Danazol—Photosensitivity—Methotrexate—colon cancer	0.00151	0.0049	CcSEcCtD
Danazol—Vertigo—Vincristine—colon cancer	0.00148	0.0048	CcSEcCtD
Danazol—Leukopenia—Vincristine—colon cancer	0.00147	0.00478	CcSEcCtD
Danazol—Vision blurred—Fluorouracil—colon cancer	0.00145	0.00469	CcSEcCtD
Danazol—Vertigo—Irinotecan—colon cancer	0.00144	0.00467	CcSEcCtD
Danazol—Syncope—Irinotecan—colon cancer	0.00144	0.00466	CcSEcCtD
Danazol—Leukopenia—Irinotecan—colon cancer	0.00144	0.00465	CcSEcCtD
Danazol—CYP3A4—liver—colon cancer	0.00143	0.00417	CbGeAlD
Danazol—Convulsion—Vincristine—colon cancer	0.00143	0.00463	CcSEcCtD
Danazol—Hypertension—Vincristine—colon cancer	0.00142	0.00461	CcSEcCtD
Danazol—Loss of consciousness—Irinotecan—colon cancer	0.00141	0.00457	CcSEcCtD
Danazol—Photosensitivity reaction—Capecitabine—colon cancer	0.00141	0.00456	CcSEcCtD
Danazol—Weight increased—Capecitabine—colon cancer	0.0014	0.00455	CcSEcCtD
Danazol—Visual disturbance—Methotrexate—colon cancer	0.0014	0.00454	CcSEcCtD
Danazol—Hypertension—Irinotecan—colon cancer	0.00138	0.00449	CcSEcCtD
Danazol—Leukopenia—Fluorouracil—colon cancer	0.00138	0.00446	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00136	0.00442	CcSEcCtD
Danazol—Acute coronary syndrome—Capecitabine—colon cancer	0.00135	0.00439	CcSEcCtD
Danazol—Myocardial infarction—Capecitabine—colon cancer	0.00135	0.00437	CcSEcCtD
Danazol—Oedema—Vincristine—colon cancer	0.00134	0.00436	CcSEcCtD
Danazol—Jaundice—Capecitabine—colon cancer	0.00134	0.00434	CcSEcCtD
Danazol—Convulsion—Fluorouracil—colon cancer	0.00133	0.00431	CcSEcCtD
Danazol—Thrombocytopenia—Vincristine—colon cancer	0.00132	0.00427	CcSEcCtD
Danazol—Haematuria—Capecitabine—colon cancer	0.00131	0.00425	CcSEcCtD
Danazol—Oedema—Irinotecan—colon cancer	0.00131	0.00424	CcSEcCtD
Danazol—Hyperhidrosis—Vincristine—colon cancer	0.0013	0.00421	CcSEcCtD
Danazol—Shock—Irinotecan—colon cancer	0.00129	0.00418	CcSEcCtD
Danazol—Thrombocytopenia—Irinotecan—colon cancer	0.00128	0.00416	CcSEcCtD
Danazol—Irritability—Methotrexate—colon cancer	0.00127	0.00411	CcSEcCtD
Danazol—Hyperhidrosis—Irinotecan—colon cancer	0.00127	0.0041	CcSEcCtD
Danazol—Mood swings—Methotrexate—colon cancer	0.00126	0.00408	CcSEcCtD
Danazol—Oedema—Fluorouracil—colon cancer	0.00125	0.00406	CcSEcCtD
Danazol—Haemoglobin—Capecitabine—colon cancer	0.00124	0.00402	CcSEcCtD
Danazol—Haemorrhage—Capecitabine—colon cancer	0.00123	0.004	CcSEcCtD
Danazol—Thrombocytopenia—Fluorouracil—colon cancer	0.00123	0.00398	CcSEcCtD
Danazol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00122	0.00397	CcSEcCtD
Danazol—Tachycardia—Fluorouracil—colon cancer	0.00122	0.00397	CcSEcCtD
Danazol—Paraesthesia—Vincristine—colon cancer	0.00121	0.00391	CcSEcCtD
Danazol—Visual impairment—Capecitabine—colon cancer	0.00119	0.00385	CcSEcCtD
Danazol—Paraesthesia—Irinotecan—colon cancer	0.00118	0.00381	CcSEcCtD
Danazol—Erythema multiforme—Capecitabine—colon cancer	0.00117	0.00378	CcSEcCtD
Danazol—Fatigue—Vincristine—colon cancer	0.00116	0.00376	CcSEcCtD
Danazol—Dyspepsia—Irinotecan—colon cancer	0.00115	0.00374	CcSEcCtD
Danazol—Constipation—Vincristine—colon cancer	0.00115	0.00373	CcSEcCtD
Danazol—Flushing—Capecitabine—colon cancer	0.00114	0.00371	CcSEcCtD
Danazol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00114	0.0037	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—colon cancer	0.00114	0.00368	CcSEcCtD
Danazol—Fatigue—Irinotecan—colon cancer	0.00113	0.00366	CcSEcCtD
Danazol—Paraesthesia—Fluorouracil—colon cancer	0.00113	0.00365	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—colon cancer	0.00112	0.00365	CcSEcCtD
Danazol—Constipation—Irinotecan—colon cancer	0.00112	0.00363	CcSEcCtD
Danazol—Chills—Capecitabine—colon cancer	0.00111	0.00359	CcSEcCtD
Danazol—Dyspepsia—Fluorouracil—colon cancer	0.0011	0.00358	CcSEcCtD
Danazol—Alopecia—Capecitabine—colon cancer	0.00109	0.00353	CcSEcCtD
Danazol—Body temperature increased—Vincristine—colon cancer	0.00106	0.00344	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—colon cancer	0.00105	0.00339	CcSEcCtD
Danazol—Back pain—Capecitabine—colon cancer	0.00104	0.00337	CcSEcCtD
Danazol—Body temperature increased—Irinotecan—colon cancer	0.00103	0.00335	CcSEcCtD
Danazol—Muscle spasms—Capecitabine—colon cancer	0.00103	0.00335	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00101	0.00329	CcSEcCtD
Danazol—Vision blurred—Capecitabine—colon cancer	0.00101	0.00328	CcSEcCtD
Danazol—Tremor—Capecitabine—colon cancer	0.00101	0.00326	CcSEcCtD
Danazol—Urticaria—Fluorouracil—colon cancer	0.000996	0.00323	CcSEcCtD
Danazol—Body temperature increased—Fluorouracil—colon cancer	0.000991	0.00321	CcSEcCtD
Danazol—Sweating—Methotrexate—colon cancer	0.00098	0.00318	CcSEcCtD
Danazol—Haematuria—Methotrexate—colon cancer	0.000975	0.00316	CcSEcCtD
Danazol—Vertigo—Capecitabine—colon cancer	0.000964	0.00313	CcSEcCtD
Danazol—Asthenia—Vincristine—colon cancer	0.000964	0.00313	CcSEcCtD
Danazol—Syncope—Capecitabine—colon cancer	0.000963	0.00312	CcSEcCtD
Danazol—Leukopenia—Capecitabine—colon cancer	0.000961	0.00312	CcSEcCtD
Danazol—Palpitations—Capecitabine—colon cancer	0.000949	0.00308	CcSEcCtD
Danazol—Loss of consciousness—Capecitabine—colon cancer	0.000943	0.00306	CcSEcCtD
Danazol—Asthenia—Irinotecan—colon cancer	0.000939	0.00304	CcSEcCtD
Danazol—Hypertension—Capecitabine—colon cancer	0.000927	0.003	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—colon cancer	0.000923	0.00299	CcSEcCtD
Danazol—Haemorrhage—Methotrexate—colon cancer	0.000918	0.00298	CcSEcCtD
Danazol—Arthralgia—Capecitabine—colon cancer	0.000914	0.00296	CcSEcCtD
Danazol—Anxiety—Capecitabine—colon cancer	0.000911	0.00295	CcSEcCtD
Danazol—Dizziness—Vincristine—colon cancer	0.000889	0.00288	CcSEcCtD
Danazol—Pruritus—Fluorouracil—colon cancer	0.000887	0.00288	CcSEcCtD
Danazol—Visual impairment—Methotrexate—colon cancer	0.000885	0.00287	CcSEcCtD
Danazol—Oedema—Capecitabine—colon cancer	0.000876	0.00284	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—colon cancer	0.000868	0.00281	CcSEcCtD
Danazol—Dizziness—Irinotecan—colon cancer	0.000866	0.00281	CcSEcCtD
Danazol—Shock—Capecitabine—colon cancer	0.000862	0.00279	CcSEcCtD
Danazol—Thrombocytopenia—Capecitabine—colon cancer	0.000858	0.00278	CcSEcCtD
Danazol—Tachycardia—Capecitabine—colon cancer	0.000855	0.00277	CcSEcCtD
Danazol—Vomiting—Vincristine—colon cancer	0.000855	0.00277	CcSEcCtD
Danazol—Rash—Vincristine—colon cancer	0.000847	0.00275	CcSEcCtD
Danazol—Hyperhidrosis—Capecitabine—colon cancer	0.000847	0.00275	CcSEcCtD
Danazol—Dermatitis—Vincristine—colon cancer	0.000847	0.00274	CcSEcCtD
Danazol—Headache—Vincristine—colon cancer	0.000842	0.00273	CcSEcCtD
Danazol—Vomiting—Irinotecan—colon cancer	0.000832	0.0027	CcSEcCtD
Danazol—Dizziness—Fluorouracil—colon cancer	0.000829	0.00269	CcSEcCtD
Danazol—Rash—Irinotecan—colon cancer	0.000825	0.00268	CcSEcCtD
Danazol—Dermatitis—Irinotecan—colon cancer	0.000825	0.00267	CcSEcCtD
Danazol—Chills—Methotrexate—colon cancer	0.000824	0.00267	CcSEcCtD
Danazol—Headache—Irinotecan—colon cancer	0.00082	0.00266	CcSEcCtD
Danazol—Alopecia—Methotrexate—colon cancer	0.000811	0.00263	CcSEcCtD
Danazol—Nausea—Vincristine—colon cancer	0.000798	0.00259	CcSEcCtD
Danazol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000798	0.00259	CcSEcCtD
Danazol—Vomiting—Fluorouracil—colon cancer	0.000797	0.00258	CcSEcCtD
Danazol—Rash—Fluorouracil—colon cancer	0.00079	0.00256	CcSEcCtD
Danazol—Dermatitis—Fluorouracil—colon cancer	0.00079	0.00256	CcSEcCtD
Danazol—Paraesthesia—Capecitabine—colon cancer	0.000787	0.00255	CcSEcCtD
Danazol—Headache—Fluorouracil—colon cancer	0.000785	0.00255	CcSEcCtD
Danazol—Nausea—Irinotecan—colon cancer	0.000778	0.00252	CcSEcCtD
Danazol—Back pain—Methotrexate—colon cancer	0.000773	0.00251	CcSEcCtD
Danazol—Dyspepsia—Capecitabine—colon cancer	0.000771	0.0025	CcSEcCtD
Danazol—Fatigue—Capecitabine—colon cancer	0.000755	0.00245	CcSEcCtD
Danazol—Vision blurred—Methotrexate—colon cancer	0.000753	0.00244	CcSEcCtD
Danazol—Constipation—Capecitabine—colon cancer	0.000749	0.00243	CcSEcCtD
Danazol—Nausea—Fluorouracil—colon cancer	0.000745	0.00241	CcSEcCtD
Danazol—Vertigo—Methotrexate—colon cancer	0.000718	0.00233	CcSEcCtD
Danazol—Leukopenia—Methotrexate—colon cancer	0.000715	0.00232	CcSEcCtD
Danazol—Urticaria—Capecitabine—colon cancer	0.000696	0.00226	CcSEcCtD
Danazol—Body temperature increased—Capecitabine—colon cancer	0.000693	0.00225	CcSEcCtD
Danazol—Convulsion—Methotrexate—colon cancer	0.000692	0.00224	CcSEcCtD
Danazol—Arthralgia—Methotrexate—colon cancer	0.00068	0.00221	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—colon cancer	0.000639	0.00207	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—colon cancer	0.00063	0.00204	CcSEcCtD
Danazol—Asthenia—Capecitabine—colon cancer	0.000629	0.00204	CcSEcCtD
Danazol—Pruritus—Capecitabine—colon cancer	0.00062	0.00201	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000594	0.00193	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—colon cancer	0.000586	0.0019	CcSEcCtD
Danazol—Dizziness—Capecitabine—colon cancer	0.000579	0.00188	CcSEcCtD
Danazol—Dyspepsia—Methotrexate—colon cancer	0.000574	0.00186	CcSEcCtD
Danazol—Fatigue—Methotrexate—colon cancer	0.000562	0.00182	CcSEcCtD
Danazol—Vomiting—Capecitabine—colon cancer	0.000557	0.00181	CcSEcCtD
Danazol—Rash—Capecitabine—colon cancer	0.000552	0.00179	CcSEcCtD
Danazol—Dermatitis—Capecitabine—colon cancer	0.000552	0.00179	CcSEcCtD
Danazol—Headache—Capecitabine—colon cancer	0.000549	0.00178	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—CDKN1A—colon cancer	0.000535	0.00154	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000532	0.00153	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	0.000522	0.0015	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000521	0.0015	CbGpPWpGaD
Danazol—Nausea—Capecitabine—colon cancer	0.00052	0.00169	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.00052	0.0015	CbGpPWpGaD
Danazol—Urticaria—Methotrexate—colon cancer	0.000518	0.00168	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000518	0.00149	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—FGFR3—colon cancer	0.000516	0.00149	CbGpPWpGaD
Danazol—Body temperature increased—Methotrexate—colon cancer	0.000516	0.00167	CcSEcCtD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.000516	0.00149	CbGpPWpGaD
Danazol—Ethinyl Estradiol—ABCB1—colon cancer	0.000513	0.212	CrCbGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000512	0.00148	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—SRC—colon cancer	0.000512	0.00148	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.000508	0.00146	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—PIK3CA—colon cancer	0.000506	0.00146	CbGpPWpGaD
Danazol—Prednisone—ABCB1—colon cancer	0.000501	0.207	CrCbGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.0005	0.00144	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—MYC—colon cancer	0.000496	0.00143	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000495	0.00143	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TGFB1—colon cancer	0.000495	0.00143	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000494	0.00142	CbGpPWpGaD
Danazol—Norethindrone—ABCB1—colon cancer	0.000494	0.204	CrCbGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	0.000493	0.00142	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000489	0.00141	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.000487	0.0014	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—EGFR—colon cancer	0.000485	0.0014	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MYC—colon cancer	0.000485	0.0014	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	0.000483	0.00139	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—NRAS—colon cancer	0.000477	0.00137	CbGpPWpGaD
Danazol—Asthenia—Methotrexate—colon cancer	0.000468	0.00152	CcSEcCtD
Danazol—Pruritus—Methotrexate—colon cancer	0.000461	0.0015	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	0.000453	0.00131	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000448	0.00129	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000438	0.00126	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	0.000436	0.00126	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000436	0.00126	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—EGFR—colon cancer	0.000434	0.00125	CbGpPWpGaD
Danazol—Dizziness—Methotrexate—colon cancer	0.000431	0.0014	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000431	0.00124	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CHST5—colon cancer	0.00043	0.00124	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ODC1—colon cancer	0.00043	0.00124	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000424	0.00122	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000424	0.00122	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.00042	0.00121	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	0.000419	0.00121	CbGpPWpGaD
Danazol—Vomiting—Methotrexate—colon cancer	0.000415	0.00134	CcSEcCtD
Danazol—Rash—Methotrexate—colon cancer	0.000411	0.00133	CcSEcCtD
Danazol—Dermatitis—Methotrexate—colon cancer	0.000411	0.00133	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—KRAS—colon cancer	0.00041	0.00118	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000409	0.00118	CbGpPWpGaD
Danazol—Headache—Methotrexate—colon cancer	0.000409	0.00132	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—TP53—colon cancer	0.000398	0.00115	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000395	0.00114	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AXIN2—colon cancer	0.000394	0.00114	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.00039	0.00112	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000389	0.00112	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000388	0.00112	CbGpPWpGaD
Danazol—Nausea—Methotrexate—colon cancer	0.000387	0.00126	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.00038	0.0011	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PIK3CA—colon cancer	0.000377	0.00109	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000375	0.00108	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.00037	0.00107	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000365	0.00105	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000361	0.00104	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000361	0.00104	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—HRAS—colon cancer	0.00036	0.00104	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.00036	0.00104	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.00036	0.00104	CbGpPWpGaD
Danazol—PGR—Gene Expression—HNF4A—colon cancer	0.000357	0.00103	CbGpPWpGaD
Danazol—Hydrocortisone—ABCB1—colon cancer	0.000353	0.146	CrCbGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000351	0.00101	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—HRAS—colon cancer	0.000349	0.00101	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000348	0.001	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—AKT1—colon cancer	0.000344	0.000991	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DLC1—colon cancer	0.000343	0.000987	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.00034	0.00098	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00034	0.00098	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000336	0.000968	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000336	0.000967	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000333	0.000959	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000327	0.000941	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000323	0.000932	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000323	0.000932	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—PPARG—colon cancer	0.000322	0.000929	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LGR5—colon cancer	0.000322	0.000928	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000318	0.000917	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—AKT1—colon cancer	0.000318	0.000917	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000314	0.000906	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	0.000314	0.000906	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000314	0.000906	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—AKT1—colon cancer	0.000308	0.000888	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000306	0.000883	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000301	0.000867	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.0003	0.000863	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000299	0.000862	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000293	0.000844	CbGpPWpGaD
Danazol—Progesterone—ABCB1—colon cancer	0.000288	0.119	CrCbGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000286	0.000825	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CTNNB1—colon cancer	0.000286	0.000823	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000285	0.000821	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000282	0.000812	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000281	0.00081	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—NRAS—colon cancer	0.00028	0.000806	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000279	0.000805	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000278	0.000801	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000276	0.000794	CbGpPWpGaD
Danazol—AR—Gene Expression—HNF4A—colon cancer	0.000272	0.000785	CbGpPWpGaD
Danazol—Testosterone—ABCB1—colon cancer	0.000272	0.112	CrCbGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000271	0.00078	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.00027	0.000779	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000268	0.000773	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000262	0.000755	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000262	0.000755	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00026	0.000751	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000256	0.000739	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—EGFR—colon cancer	0.000255	0.000735	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000249	0.000718	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PPARG—colon cancer	0.000246	0.000708	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000242	0.000698	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000242	0.000698	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—KRAS—colon cancer	0.000241	0.000694	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.00024	0.000693	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000239	0.00069	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000236	0.00068	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000236	0.00068	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000231	0.000667	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AXIN2—colon cancer	0.000231	0.000667	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	0.000221	0.000638	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000217	0.000626	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000217	0.000624	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000215	0.00062	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000212	0.000612	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HNF4A—colon cancer	0.00021	0.000605	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA7—colon cancer	0.000207	0.000597	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—colon cancer	0.000205	0.00059	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000203	0.000585	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000201	0.000578	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGFR3—colon cancer	0.000197	0.000569	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000195	0.000563	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—colon cancer	0.000189	0.000545	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000184	0.000531	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—colon cancer	0.000184	0.00053	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000182	0.000524	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APC—colon cancer	0.000181	0.000522	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—NRAS—colon cancer	0.000181	0.000522	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—colon cancer	0.000181	0.000521	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGFR3—colon cancer	0.000181	0.00052	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000178	0.000514	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000178	0.000512	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BRAF—colon cancer	0.00017	0.000491	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APC—colon cancer	0.000166	0.000478	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—NRAS—colon cancer	0.000166	0.000478	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—colon cancer	0.000165	0.000476	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—KRAS—colon cancer	0.000156	0.00045	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BRAF—colon cancer	0.000156	0.000449	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—colon cancer	0.000155	0.000447	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—colon cancer	0.000151	0.000435	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000151	0.000434	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—colon cancer	0.000144	0.000416	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—colon cancer	0.000143	0.000413	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KRAS—colon cancer	0.000143	0.000411	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—colon cancer	0.00014	0.000403	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.00014	0.000403	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—colon cancer	0.000133	0.000382	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—colon cancer	0.000131	0.000378	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—colon cancer	0.000128	0.000368	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CHST5—colon cancer	0.000126	0.000362	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ODC1—colon cancer	0.000126	0.000362	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—colon cancer	0.000124	0.000358	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—colon cancer	0.000123	0.000355	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—colon cancer	0.000121	0.00035	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—colon cancer	0.00012	0.000347	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—colon cancer	0.000118	0.000341	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—colon cancer	0.000118	0.00034	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—colon cancer	0.000117	0.000337	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—colon cancer	0.000117	0.000337	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000116	0.000335	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EP300—colon cancer	0.000114	0.00033	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGFR3—colon cancer	0.000114	0.000328	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—colon cancer	0.000114	0.000328	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—colon cancer	0.000114	0.000328	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—colon cancer	0.000113	0.000325	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMS—colon cancer	0.000112	0.000322	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—colon cancer	0.000111	0.000321	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—colon cancer	0.00011	0.000317	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—colon cancer	0.000108	0.000312	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—colon cancer	0.000108	0.000311	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—colon cancer	0.000107	0.000309	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRAS—colon cancer	0.000107	0.000309	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EP300—colon cancer	0.000105	0.000302	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—colon cancer	0.000105	0.000301	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—colon cancer	0.000102	0.000293	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—colon cancer	9.97e-05	0.000287	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—colon cancer	9.95e-05	0.000287	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—colon cancer	9.91e-05	0.000286	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BRAF—colon cancer	9.82e-05	0.000283	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRAS—colon cancer	9.79e-05	0.000282	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—colon cancer	9.75e-05	0.000281	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—colon cancer	9.21e-05	0.000266	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—colon cancer	9.12e-05	0.000263	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—colon cancer	9.11e-05	0.000262	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—colon cancer	9.1e-05	0.000262	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—colon cancer	8.92e-05	0.000257	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—colon cancer	8.85e-05	0.000255	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.6e-05	0.000248	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—colon cancer	8.47e-05	0.000244	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—colon cancer	8.43e-05	0.000243	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—colon cancer	8.19e-05	0.000236	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—colon cancer	7.91e-05	0.000228	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—colon cancer	7.83e-05	0.000226	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—colon cancer	7.74e-05	0.000223	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—colon cancer	7.49e-05	0.000216	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—colon cancer	7.37e-05	0.000212	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—colon cancer	7.17e-05	0.000207	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—colon cancer	7.16e-05	0.000206	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—colon cancer	7.1e-05	0.000205	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—colon cancer	6.94e-05	0.0002	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—colon cancer	6.92e-05	0.000199	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—colon cancer	6.74e-05	0.000194	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR3—colon cancer	6.68e-05	0.000193	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EP300—colon cancer	6.6e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—colon cancer	6.42e-05	0.000185	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—colon cancer	6.32e-05	0.000182	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—colon cancer	6.25e-05	0.00018	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—colon cancer	6.22e-05	0.000179	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRAS—colon cancer	6.17e-05	0.000178	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—colon cancer	6.13e-05	0.000177	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—colon cancer	6.13e-05	0.000177	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BRAF—colon cancer	5.77e-05	0.000166	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—colon cancer	5.75e-05	0.000166	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—colon cancer	5.74e-05	0.000165	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—colon cancer	5.63e-05	0.000162	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—colon cancer	5.31e-05	0.000153	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—colon cancer	5.19e-05	0.00015	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—EP300—colon cancer	5.17e-05	0.000149	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—colon cancer	4.88e-05	0.000141	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—colon cancer	4.72e-05	0.000136	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—colon cancer	4.67e-05	0.000135	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—colon cancer	4.52e-05	0.00013	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—colon cancer	4.32e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—colon cancer	4.21e-05	0.000121	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—colon cancer	4.17e-05	0.00012	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—colon cancer	4.07e-05	0.000117	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—colon cancer	3.99e-05	0.000115	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EP300—colon cancer	3.87e-05	0.000112	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—colon cancer	3.83e-05	0.00011	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—colon cancer	3.77e-05	0.000109	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—colon cancer	3.67e-05	0.000106	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRAS—colon cancer	3.62e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—colon cancer	3.6e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—colon cancer	3.38e-05	9.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—colon cancer	3.37e-05	9.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—colon cancer	3.32e-05	9.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—colon cancer	3.3e-05	9.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMS—colon cancer	3.26e-05	9.39e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—colon cancer	3.13e-05	9.01e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—colon cancer	3.12e-05	8.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—colon cancer	2.87e-05	8.26e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—colon cancer	2.77e-05	7.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—colon cancer	2.65e-05	7.64e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—colon cancer	2.34e-05	6.75e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—colon cancer	2.31e-05	6.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—colon cancer	1.82e-05	5.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EP300—colon cancer	1.51e-05	4.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—colon cancer	1.12e-05	3.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—colon cancer	9.13e-06	2.63e-05	CbGpPWpGaD
